David Berry’s Valo feeds its capital needs with $110M from new backer to build Opal

A $110 million venture infusion will enable Valo to build out its AI-based computational drug discovery and development platform and support its pipeline programs.

The Koch Disruptive Technologies’ investment brings Boston-based Valo Health LLC’s series B financing to $300 million and the company’s total funding to more than $450 million. ...